In Vivo Engineering of CAR-T & CAR-NK for Autoimmune Disease

Time: 11:30 am
day: Conference Day One


  • Engineering T and NK cells directly in vivo to create antigen-specific CAR cells
  • Bypassing and eliminating all aspects of ex vivo cell manufacturing
  • Creating “faster, better, cheaper” autologous CAR cells without the need for chemotherapy